Nitrous Oxide Pain Relief Works by Releasing the Opioid Peptide Dynorphin in the Brain

Nitrous oxide (laughing gas) produces pain relief by stimulating the release of dynorphin in the brain, which then activates kappa opioid receptors — blocking dynorphin eliminates the analgesic effect.

Branda, E M et al.·Pharmacology·2000·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-00582Animal StudyPreliminary Evidence2000RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Intracerebroventricular dynorphin antibodies completely blocked nitrous oxide antinociception, proving that N2O analgesic effect is mediated by neuronal release of endogenous dynorphin activating kappa opioid receptors.

Key Numbers

How They Did This

Animal study in mice. ICV injection of anti-dynorphin antibodies before nitrous oxide exposure. Pain response measured by abdominal constriction test. Controls included anti-endorphin and anti-enkephalin antibodies.

Why This Research Matters

Understanding that nitrous oxide works through dynorphin explains its unique analgesic properties and suggests dynorphin-based drugs could provide similar pain relief with fewer anesthetic side effects.

The Bigger Picture

This elegant study shows even well-known drugs can work through unexpected peptide intermediaries. Many analgesics and anesthetics may operate by triggering endogenous opioid release rather than directly binding receptors.

What This Study Doesn't Tell Us

Mouse study. ICV antibody injection is not a clinical intervention. The specific brain regions where dynorphin is released during nitrous oxide exposure were not mapped.

Questions This Raises

  • ?Could kappa-selective drugs provide nitrous oxide-like analgesia?
  • ?Does chronic nitrous oxide use deplete brain dynorphin stores?
  • ?What triggers dynorphin release from neurons during N2O exposure?

Trust & Context

Key Stat:
Complete block Anti-dynorphin antibodies completely eliminated nitrous oxide's pain relief, while anti-endorphin and anti-enkephalin had no effect
Evidence Grade:
Preliminary but compelling animal evidence using selective antibody blocking to demonstrate a specific peptide mediator.
Study Age:
Published in 2000. The dynorphin-mediated mechanism of nitrous oxide analgesia has been further characterized in subsequent studies.
Original Title:
Role of brain dynorphin in nitrous oxide antinociception in mice.
Published In:
Pharmacology, biochemistry, and behavior, 65(2), 217-21 (2000)
Database ID:
RPEP-00582

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

How does laughing gas relieve pain?

It triggers your brain to release dynorphin, a natural painkiller. The dynorphin then activates opioid receptors to reduce pain. So nitrous oxide doesn't directly kill pain — it causes your brain to release its own painkillers.

Is this the same as taking opioid drugs?

Similar concept but different mechanism. Nitrous oxide triggers a natural, controlled release of a specific opioid peptide (dynorphin), while opioid drugs directly flood all opioid receptors. This may explain why nitrous oxide is safer and less addictive.

Read More on RethinkPeptides

Cite This Study

RPEP-00582·https://rethinkpeptides.com/research/RPEP-00582

APA

Branda, E M; Ramza, J T; Cahill, F J; Tseng, L F; Quock, R M. (2000). Role of brain dynorphin in nitrous oxide antinociception in mice.. Pharmacology, biochemistry, and behavior, 65(2), 217-21.

MLA

Branda, E M, et al. "Role of brain dynorphin in nitrous oxide antinociception in mice.." Pharmacology, 2000.

RethinkPeptides

RethinkPeptides Research Database. "Role of brain dynorphin in nitrous oxide antinociception in ..." RPEP-00582. Retrieved from https://rethinkpeptides.com/research/branda-2000-role-of-brain-dynorphin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.